Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways
about
A role for the androgen metabolite, 5alpha androstane 3beta, 17beta diol (3β-diol) in the regulation of the hypothalamo-pituitary-adrenal axisEstrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAsEstradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cellsEffects of the lifestyle habits in breast cancer transcriptional regulationSilent Polymorphisms: Can the tRNA Population Explain Changes in Protein Properties?What's new in estrogen receptor action in the female reproductive tractThe structural biology of oestrogen metabolismEstrogen receptors and the regulation of neural stress responsesCyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivoA role for Sp1 in transcriptional regulation of phosphatidylethanolamine N-methyltransferase in liver and 3T3-L1 adipocytesToxicogenomic and phenotypic analyses of bisphenol-A early-life exposure toxicity in zebrafishdynorphin-kappa opioid receptor signaling partly mediates estrogen negative feedback effect on LH pulses in female ratsHormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the kneeNovel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studiesGenome-wide association study of recurrent early-onset major depressive disorderAssessment and molecular actions of endocrine-disrupting chemicals that interfere with estrogen receptor pathways.Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain.Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elementsLiganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements.Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulationDown-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex.Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT.Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERalpha and c-Jun.CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter.Ecdysone and the cell cycle: investigations in a mosquito cell line.3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters.Serine protease PRSS23 is upregulated by estrogen receptor α and associated with proliferation of breast cancer cells.Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.Development of subtype-selective oestrogen receptor-based therapeutics.The role of hypothalamic estrogen receptors in metabolic regulation.The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy.Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.Estrogenic activity of bisphenol A and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles.Sex difference in irritable bowel syndrome: do gonadal hormones play a role?Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.Classical nuclear hormone receptor activity as a mediator of complex concentration response relationships for endocrine active compoundsEstrogenic potency of benzophenone UV filters in breast cancer cells: proliferative and transcriptional activity substantiated by docking analysis
P2860
Q21131285-B31931D4-96DF-45F6-87BE-BF20F6CF2157Q24631037-2797AE49-73E1-4A0F-8D5D-7851D3108931Q24649539-86DCC3D9-3E22-4572-87A8-5303ED711DF4Q26766093-4BE3D1AC-7936-4F4F-B249-D3D58F94C277Q26768439-7F25C919-FC80-48B9-BA53-1C5B7E4E6A4EQ26772956-B9A0E054-A794-4862-97F3-BB19C753C9ACQ27009283-9EDCCD99-5DB5-477B-866E-BC4E478B7C43Q27021515-11B73740-E1D9-46EE-B4B9-D4F80AC6BA63Q27302901-32CF462C-82C5-4062-A9A3-1A6F8664C983Q28273059-745466C7-D967-44BA-9C6A-25DC6B42C19BQ28478402-69698921-1408-46B4-9C84-0E0C2BE359C7Q28570263-036607A2-850F-4524-BB78-5FE04ADC4ED3Q28706277-B8AC2C69-6240-4B59-98B7-4B96E83C4881Q28751388-C8AFBDE5-2F06-4E7C-A3DB-EBE0FFC1394CQ28943558-524A5CB4-1DA0-4772-93DB-653A736E3CDEQ30393711-34A459E7-6E4B-429C-8721-9E7AD685CB85Q33522839-03A3DF40-A86A-4DE2-96F2-BC6E376661FBQ33594026-A9BA604D-8D55-423E-BA66-232262C60078Q33631509-34181C4C-D4B8-4A28-B8AD-B7BB1DF60505Q33783157-BFBC7A17-841D-450C-8FFC-4257137A570BQ33793540-1F1EF117-7668-4132-8BF9-7296125B690BQ33809942-0A06F495-1852-4DC0-B7F3-E5CC0980C5B9Q33853052-08A69893-3B9E-48D3-89B3-2A642E982EE7Q33853065-6AE1731E-9C1E-4BE3-BCB3-BAA638F380DEQ34029386-0806D006-51C9-40A6-979E-D387AFC24DD6Q34054117-4B57AE28-CF65-4D81-8A94-700D8936E173Q34072030-DBD46A62-E60C-4BA5-927D-8ADA74201740Q34146042-A22AA67C-8CA9-479A-9490-D8E8E3CD2FE8Q34180982-FBE26A31-0794-49EA-BA06-20084411678EQ34181200-56A4EDE6-E6A9-4615-B8BF-89835CEA225DQ34216817-FDC9F10E-3BFF-438B-A16B-3A08040DD9FDQ34243150-A3EFBFA2-2BB3-4DC8-8334-4212C6FF3230Q34311300-4AD49B77-F91E-413E-B5CC-B005D52C6E75Q34324898-390D7599-3D52-40B3-AA48-70677167AAD3Q34374852-05C9E3CE-EB5A-46F9-8E47-5BB5816979B2Q34478546-4D13896F-3269-48F1-94E9-F69B05553AD9Q34575108-BB64B14D-021B-4137-9BAF-971FA9B049A4Q34607003-554AD038-9731-4DD5-9C32-DF11D4A4232FQ34660998-F23C0425-2EF4-4244-8348-3238F6FCF539Q34673424-B05BDB38-3D4A-4A54-AFDB-2605BFAE53B2
P2860
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Non-classical genomic estrogen ...... g protein-1 signaling pathways
@en
type
label
Non-classical genomic estrogen ...... g protein-1 signaling pathways
@en
prefLabel
Non-classical genomic estrogen ...... g protein-1 signaling pathways
@en
P2860
P356
P1476
Non-classical genomic estrogen ...... g protein-1 signaling pathways
@en
P2093
Kyounghyun Kim
Stephen Safe
P2860
P304
P356
10.1677/JME-08-0103
P577
2008-09-04T00:00:00Z